CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Vedanta Biosciences Inc. v. Seres Therapeutics, Inc.

1:24-cv-00957

Overview

Case Number 1:24-cv-00957
Filing Date 2024-08-20
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:1 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Nestle HealthCare Nutrition, Inc. Operating Company

Represented By

1 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Aimmune Therapeutics, Inc. Operating Company

Represented By

1 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

NHSc RX License GmbH Operating Company

Represented By

3 Attorneys Listed

Nan Zhang

Email: nzhang@mayerbrown.com

Carmine R. Zarlenga

Email: czarlenga@mayerbrown.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Nestle Health Science US Holdings, Inc. NPE (Patent Assertion Entity)

Represented By

0 Attorneys Listed
No attorneys available

Nestle Health Science S.A. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Societe des Produits Nestle S.A. Operating Company

Represented By

3 Attorneys Listed

Nan Zhang

Email: nzhang@mayerbrown.com

Carmine R. Zarlenga

Email: czarlenga@mayerbrown.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Nestle S.A. NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Nan Zhang

Email: nzhang@mayerbrown.com

Carmine R. Zarlenga

Email: czarlenga@mayerbrown.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Seres Therapeutics, Inc. Operating Company

Represented By

1 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Plaintiff

The University of Tokyo NPE (University / Research)

Represented By

5 Attorneys Listed

Joshua D. Calabro

Email: jcalabro@Venable.com

Dominick A. Conde

Email: dconde@venable.com

Daniel A. O'Brien

Venable LLP

Tel: +1 (302) 298-3523
Fax: +1 (302) 298-3550

1201 N. Market Street, Suite 1400, Wilmington, DE 19801

Damien N. Dombrowski

Email: ddombrowski@venable.com

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 576-1600

222 Delaware Avenue, Suite 1600

Vedanta Biosciences Inc. Operating Company

Represented By

5 Attorneys Listed

Joshua D. Calabro

Email: jcalabro@Venable.com

Dominick A. Conde

Email: dconde@venable.com

Daniel A. O'Brien

Venable LLP

Tel: +1 (302) 298-3523
Fax: +1 (302) 298-3550

1201 N. Market Street, Suite 1400, Wilmington, DE 19801

Damien N. Dombrowski

Email: ddombrowski@venable.com

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 576-1600

222 Delaware Avenue, Suite 1600

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 24 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (24): 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9433652
Composition for inducing proliferation or accumulation of regulatory T cells
Filed: 2014-09-22
Issued: 2016-09-06
Active (4.7 yrs remaining)
Expires: 2031-08-16
US9662381
Composition for inducing proliferation or accumulation of regulatory T cells
Filed: 2016-12-09
Issued: 2017-05-30
Active (10.1 yrs remaining)
Expires: 2036-12-09
US9808519
Composition for inducing proliferation or accumulation of regulatory T cells
Filed: 2017-05-09
Issued: 2017-11-07
Active (10.5 yrs remaining)
Expires: 2037-05-09
US10555978
Composition for inducing proliferation or accumulation of regulatory T cells
Filed: 2019-05-29
Issued: 2020-02-11
Active (12.5 yrs remaining)
Expires: 2039-05-29
US11090343
Composition for inducing proliferation or accumulation of regulatory T cells
Filed: 2020-02-03
Issued: 2021-08-17
Active (13.2 yrs remaining)
Expires: 2040-02-03

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

23

Dispositive

19

Granted

1

Denied

1

Pending / Review

19

Motions by Category

Procedural / Extension Motion 3 Motion to Dismiss 19 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Motion to Dismiss Denied
ORDER: The motion to dismiss (D.I. 18 ) is DENIED (see full Order for further details). Signed by Judge Richard G. Andrews on 2/3/2026. (aas) (Entered: 02/03/20...
Entry #52 • 2026-02-03 Document →
Motion to Dismiss Granted
ORDER: The Report and Recommendation (D.I. 49 ) is ADOPTED. Defendants Nestle S.A. and NHSc Rx License GmbH motions to dismiss for lack of personal jurisdiction...
Entry #50 • 2025-12-22 Document →
Motion to Dismiss Pending / Under Review
REPORT AND RECOMMENDATION re 29, 32 & 35 . The Court recommends that Nestle S.A.'s and NHS Rx's motions to dismiss for lack of personal jurisdiction (D.I. 29 & ...
Entry #49 • 2025-12-02 Document →
Motion to Dismiss Pending / Under Review
REPLY BRIEF re 29 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Nestle S.A.. (Tigan, Jeremy) (Entered: 05/16/2025)
Entry #43 • 2025-05-16 Document →
Motion to Dismiss Pending / Under Review
REPLY BRIEF re 35 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by NHSc RX License GmbH. (Tigan, Jeremy) (Entered: 05/16/2025)
Entry #44 • 2025-05-16 Document →
Motion to Dismiss Pending / Under Review
REPLY BRIEF re 32 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Societe des Produits Nestle S.A.. (Tigan, Jeremy) (Entered: 05/16/2025)
Entry #45 • 2025-05-16 Document →

Docket Entries

(104 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against Nestle Health Science S.A., Nestle Health Science US Holdings, Inc., Nestle S.A., Seres Therapeutics, Inc., Societe des Produits Nestle S.A. ( Filing fee $ 405, receipt number ADEDC-4479986.) - filed by Vedanta Biosciences Inc., The University of Tokyo. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Civil Cover Sheet)(mpb) (Entered: 08/20/2024)

Entry #1 • 2024-08-20
1
Pleading / Complaint

COMPLAINT filed with Jury Demand against Nestle Health Science S.A., Nestle Health Science US Holdings, Inc., Nestle S.A., Seres Therapeutics, Inc., Societe des Produits Nestle S.A. ( Filing fee $ 405, receipt number ADEDC-4479986.) - filed by Vedanta Biosciences Inc., The University of Tokyo. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Civil Cover Sheet)(mpb) (Entered: 08/20/2024)

Entry #1 • 2024-08-20
2
Pleading / Complaint

COMPLAINT filed with Jury Demand against Nestle Health Science S.A., Nestle Health Science US Holdings, Inc., Nestle S.A., Seres Therapeutics, Inc., Societe des Produits Nestle S.A. ( Filing fee $ 405, receipt number ADEDC-4479986.) - filed by Vedanta Biosciences Inc., The University of Tokyo. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Civil Cover Sheet)(mpb) (Entered: 08/20/2024)

Entry #1 • 2024-08-20
2
Pleading / Complaint

COMPLAINT filed with Jury Demand against Nestle Health Science S.A., Nestle Health Science US Holdings, Inc., Nestle S.A., Seres Therapeutics, Inc., Societe des Produits Nestle S.A. ( Filing fee $ 405, receipt number ADEDC-4479986.) - filed by Vedanta Biosciences Inc., The University of Tokyo. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Civil Cover Sheet)(mpb) (Entered: 08/20/2024)

Entry #1 • 2024-08-20
2
Pleading / Complaint

COMPLAINT filed with Jury Demand against Nestle Health Science S.A., Nestle Health Science US Holdings, Inc., Nestle S.A., Seres Therapeutics, Inc., Societe des Produits Nestle S.A. ( Filing fee $ 405, receipt number ADEDC-4479986.) - filed by Vedanta Biosciences Inc., The University of Tokyo. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Civil Cover Sheet)(mpb) (Entered: 08/20/2024)

Entry #1 • 2024-08-20
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc